 David Bortz
Concepts (235)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Models, Biological | 17 | 2026 | 1822 | 3.480 |
Why?
| | Prefrontal Cortex | 5 | 2023 | 328 | 2.060 |
Why?
| | Ventral Tegmental Area | 4 | 2023 | 60 | 2.000 |
Why?
| | Dopaminergic Neurons | 4 | 2023 | 67 | 1.980 |
Why?
| | Nonlinear Dynamics | 5 | 2026 | 95 | 1.980 |
Why?
| | Glutamic Acid | 5 | 2017 | 251 | 1.580 |
Why?
| | Mathematical Concepts | 5 | 2026 | 36 | 1.380 |
Why?
| | Substantia Nigra | 3 | 2022 | 63 | 1.290 |
Why?
| | Population Dynamics | 3 | 2025 | 158 | 1.080 |
Why?
| | Computer Simulation | 13 | 2026 | 1026 | 1.040 |
Why?
| | Klebsiella pneumoniae | 6 | 2012 | 47 | 0.900 |
Why?
| | Algorithms | 7 | 2026 | 1839 | 0.780 |
Why?
| | Models, Theoretical | 7 | 2020 | 582 | 0.660 |
Why?
| | Electrolysis | 1 | 2020 | 2 | 0.660 |
Why?
| | Nucleus Accumbens | 3 | 2017 | 135 | 0.650 |
Why?
| | Reversal Learning | 2 | 2019 | 10 | 0.630 |
Why?
| | Methane | 1 | 2020 | 51 | 0.630 |
Why?
| | Dopamine | 1 | 2022 | 289 | 0.610 |
Why?
| | Machine Learning | 1 | 2025 | 587 | 0.610 |
Why?
| | Septal Nuclei | 1 | 2019 | 23 | 0.590 |
Why?
| | Keratinocytes | 2 | 2021 | 250 | 0.590 |
Why?
| | Septum of Brain | 1 | 2018 | 4 | 0.560 |
Why?
| | Heat-Shock Proteins | 1 | 2018 | 138 | 0.530 |
Why?
| | Systems Biology | 3 | 2026 | 72 | 0.520 |
Why?
| | Transaminases | 1 | 2017 | 22 | 0.510 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 2 | 2016 | 93 | 0.500 |
Why?
| | Longevity | 1 | 2018 | 173 | 0.500 |
Why?
| | N-Methylaspartate | 4 | 2018 | 43 | 0.490 |
Why?
| | Software | 2 | 2023 | 692 | 0.490 |
Why?
| | Isoxazoles | 1 | 2016 | 54 | 0.480 |
Why?
| | Anilides | 1 | 2016 | 84 | 0.470 |
Why?
| | Rats | 6 | 2023 | 5614 | 0.470 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2018 | 210 | 0.470 |
Why?
| | Biofilms | 5 | 2013 | 278 | 0.460 |
Why?
| | Bacterial Adhesion | 2 | 2013 | 110 | 0.460 |
Why?
| | Choline | 1 | 2016 | 136 | 0.450 |
Why?
| | Rats, Wistar | 5 | 2017 | 451 | 0.440 |
Why?
| | Caenorhabditis elegans | 1 | 2018 | 337 | 0.430 |
Why?
| | Electrochemistry | 1 | 2014 | 74 | 0.430 |
Why?
| | Chondroitin Sulfates | 1 | 2014 | 35 | 0.430 |
Why?
| | Wound Healing | 2 | 2021 | 351 | 0.430 |
Why?
| | Patient-Specific Modeling | 1 | 2014 | 45 | 0.420 |
Why?
| | Microspheres | 1 | 2014 | 142 | 0.420 |
Why?
| | Metabolic Networks and Pathways | 1 | 2015 | 187 | 0.410 |
Why?
| | Computational Biology | 3 | 2026 | 681 | 0.400 |
Why?
| | Enzyme Inhibitors | 1 | 2017 | 826 | 0.400 |
Why?
| | Excitatory Amino Acid Agonists | 3 | 2018 | 42 | 0.390 |
Why?
| | Dictyostelium | 1 | 2012 | 11 | 0.380 |
Why?
| | Cell Movement | 2 | 2021 | 965 | 0.370 |
Why?
| | Animals | 16 | 2026 | 38109 | 0.370 |
Why?
| | Biophysics | 1 | 2012 | 74 | 0.370 |
Why?
| | Hippocampus | 2 | 2018 | 967 | 0.360 |
Why?
| | Nicotinic Agonists | 1 | 2013 | 137 | 0.360 |
Why?
| | Kinetics | 5 | 2016 | 1629 | 0.350 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2013 | 280 | 0.340 |
Why?
| | Receptors, Nicotinic | 1 | 2013 | 323 | 0.330 |
Why?
| | HIV-1 | 3 | 2006 | 896 | 0.330 |
Why?
| | Cartilage, Articular | 1 | 2014 | 343 | 0.320 |
Why?
| | Microfluidics | 1 | 2011 | 62 | 0.320 |
Why?
| | Precision Medicine | 1 | 2014 | 458 | 0.310 |
Why?
| | Mechanotransduction, Cellular | 1 | 2011 | 122 | 0.310 |
Why?
| | Polyethylene Glycols | 1 | 2014 | 655 | 0.300 |
Why?
| | Cyanobacteria | 2 | 2020 | 55 | 0.300 |
Why?
| | Movement | 1 | 2011 | 294 | 0.290 |
Why?
| | Signal Transduction | 3 | 2018 | 5233 | 0.270 |
Why?
| | HIV Infections | 5 | 2006 | 3154 | 0.260 |
Why?
| | Flocculation | 3 | 2013 | 7 | 0.250 |
Why?
| | Staphylococcus epidermidis | 3 | 2013 | 79 | 0.250 |
Why?
| | Neural Pathways | 2 | 2019 | 311 | 0.240 |
Why?
| | HIV | 2 | 2004 | 250 | 0.240 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2006 | 87 | 0.240 |
Why?
| | Diabetes Mellitus | 1 | 2014 | 1098 | 0.230 |
Why?
| | Kynurenine | 2 | 2017 | 114 | 0.220 |
Why?
| | Blood Glucose | 1 | 2014 | 2330 | 0.200 |
Why?
| | Pars Compacta | 1 | 2023 | 4 | 0.200 |
Why?
| | Elasticity | 2 | 2014 | 184 | 0.200 |
Why?
| | Complement C5a | 2 | 2013 | 54 | 0.190 |
Why?
| | Rats, Sprague-Dawley | 2 | 2019 | 2540 | 0.190 |
Why?
| | Hydrodynamics | 2 | 2013 | 47 | 0.190 |
Why?
| | Numerical Analysis, Computer-Assisted | 3 | 2014 | 18 | 0.190 |
Why?
| | Scopolamine Derivatives | 1 | 2022 | 3 | 0.190 |
Why?
| | Bicuculline | 1 | 2022 | 18 | 0.190 |
Why?
| | Models, Statistical | 1 | 2006 | 682 | 0.180 |
Why?
| | Bacteremia | 4 | 2013 | 221 | 0.180 |
Why?
| | Adherens Junctions | 1 | 2021 | 24 | 0.180 |
Why?
| | Ligands | 2 | 2014 | 674 | 0.180 |
Why?
| | Cognition | 2 | 2023 | 1269 | 0.170 |
Why?
| | Hydrogen | 1 | 2020 | 73 | 0.160 |
Why?
| | Bioreactors | 1 | 2020 | 50 | 0.160 |
Why?
| | Disease Transmission, Infectious | 1 | 2020 | 69 | 0.160 |
Why?
| | Kynurenic Acid | 2 | 2017 | 18 | 0.160 |
Why?
| | Communicable Disease Control | 1 | 2020 | 86 | 0.160 |
Why?
| | Male | 8 | 2023 | 72406 | 0.150 |
Why?
| | Photosynthesis | 1 | 2020 | 98 | 0.150 |
Why?
| | Peptide Hormones | 1 | 2018 | 11 | 0.140 |
Why?
| | Receptor, Insulin | 1 | 2018 | 94 | 0.140 |
Why?
| | Amphetamine | 1 | 2018 | 38 | 0.140 |
Why?
| | Globus Pallidus | 1 | 2018 | 25 | 0.140 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2018 | 59 | 0.130 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 192 | 0.130 |
Why?
| | Heat-Shock Response | 1 | 2018 | 78 | 0.130 |
Why?
| | Animals, Genetically Modified | 1 | 2018 | 250 | 0.130 |
Why?
| | Betacoronavirus | 1 | 2020 | 286 | 0.130 |
Why?
| | Drug Administration Routes | 1 | 2017 | 44 | 0.130 |
Why?
| | Microdialysis | 1 | 2017 | 56 | 0.130 |
Why?
| | Heterocyclic Compounds, 3-Ring | 1 | 2017 | 44 | 0.130 |
Why?
| | Electrodes | 1 | 2017 | 115 | 0.120 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2018 | 381 | 0.120 |
Why?
| | alpha Catenin | 1 | 2016 | 11 | 0.120 |
Why?
| | Allosteric Regulation | 1 | 2016 | 98 | 0.120 |
Why?
| | Thiazolidinediones | 1 | 2017 | 139 | 0.120 |
Why?
| | Central Nervous System Stimulants | 1 | 2018 | 185 | 0.120 |
Why?
| | Time Factors | 4 | 2016 | 7183 | 0.120 |
Why?
| | Phenylurea Compounds | 1 | 2016 | 112 | 0.120 |
Why?
| | Epidermal Growth Factor | 1 | 2016 | 171 | 0.110 |
Why?
| | Bacterial Proteins | 2 | 2020 | 962 | 0.110 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 384 | 0.110 |
Why?
| | Biochemical Phenomena | 1 | 2015 | 9 | 0.110 |
Why?
| | Coronavirus Infections | 1 | 2020 | 378 | 0.110 |
Why?
| | Probability | 2 | 2014 | 312 | 0.110 |
Why?
| | Pandemics | 2 | 2021 | 1695 | 0.110 |
Why?
| | Adhesiveness | 1 | 2014 | 18 | 0.110 |
Why?
| | Salts | 1 | 2014 | 37 | 0.110 |
Why?
| | Exocytosis | 1 | 2015 | 84 | 0.110 |
Why?
| | Cell Adhesion | 1 | 2016 | 455 | 0.110 |
Why?
| | Sulfates | 1 | 2014 | 49 | 0.110 |
Why?
| | Osmolar Concentration | 1 | 2014 | 167 | 0.110 |
Why?
| | Static Electricity | 1 | 2014 | 113 | 0.110 |
Why?
| | Administration, Oral | 1 | 2017 | 848 | 0.110 |
Why?
| | Gels | 1 | 2014 | 84 | 0.110 |
Why?
| | Sodium Channel Blockers | 1 | 2014 | 24 | 0.100 |
Why?
| | Solvents | 1 | 2014 | 113 | 0.100 |
Why?
| | Calibration | 1 | 2014 | 151 | 0.100 |
Why?
| | RNA Interference | 1 | 2016 | 476 | 0.100 |
Why?
| | Analysis of Variance | 1 | 2017 | 1311 | 0.100 |
Why?
| | Diffusion | 1 | 2014 | 122 | 0.100 |
Why?
| | Solutions | 1 | 2014 | 167 | 0.100 |
Why?
| | Tetrodotoxin | 1 | 2014 | 40 | 0.100 |
Why?
| | Microelectrodes | 1 | 2014 | 47 | 0.100 |
Why?
| | Sulfonylurea Compounds | 1 | 2014 | 51 | 0.100 |
Why?
| | Biological Clocks | 1 | 2014 | 49 | 0.100 |
Why?
| | Humans | 15 | 2025 | 144957 | 0.100 |
Why?
| | Cross-Linking Reagents | 1 | 2014 | 207 | 0.100 |
Why?
| | Bacteria | 1 | 2020 | 889 | 0.100 |
Why?
| | Staphylococcal Infections | 3 | 2013 | 390 | 0.100 |
Why?
| | Catheters, Indwelling | 1 | 2014 | 96 | 0.100 |
Why?
| | Insulin | 2 | 2015 | 2507 | 0.100 |
Why?
| | Electrodes, Implanted | 1 | 2014 | 115 | 0.100 |
Why?
| | Motor Activity | 1 | 2018 | 722 | 0.100 |
Why?
| | Biological Evolution | 1 | 2017 | 488 | 0.100 |
Why?
| | Schizophrenia | 2 | 2014 | 446 | 0.100 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2014 | 561 | 0.100 |
Why?
| | Virus Replication | 3 | 2004 | 529 | 0.100 |
Why?
| | Bacterial Physiological Phenomena | 1 | 2013 | 60 | 0.100 |
Why?
| | ErbB Receptors | 1 | 2016 | 629 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 2032 | 0.090 |
Why?
| | Animal Distribution | 1 | 2012 | 28 | 0.090 |
Why?
| | Intestinal Mucosa | 1 | 2018 | 676 | 0.090 |
Why?
| | Internet | 1 | 2017 | 700 | 0.090 |
Why?
| | Moths | 1 | 2012 | 52 | 0.090 |
Why?
| | Animals, Newborn | 1 | 2014 | 902 | 0.090 |
Why?
| | Water | 1 | 2014 | 469 | 0.080 |
Why?
| | Bacterial Capsules | 1 | 2011 | 33 | 0.080 |
Why?
| | Drug Resistance, Bacterial | 1 | 2012 | 199 | 0.080 |
Why?
| | Metformin | 1 | 2014 | 319 | 0.080 |
Why?
| | Cell Count | 1 | 2011 | 321 | 0.080 |
Why?
| | Polymers | 1 | 2014 | 499 | 0.080 |
Why?
| | Cell Line | 1 | 2016 | 2882 | 0.080 |
Why?
| | Insulin-Secreting Cells | 1 | 2015 | 388 | 0.080 |
Why?
| | Immunity, Innate | 2 | 2013 | 846 | 0.080 |
Why?
| | Disease Models, Animal | 2 | 2014 | 4569 | 0.080 |
Why?
| | Microbial Viability | 1 | 2009 | 90 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2018 | 2609 | 0.070 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2014 | 675 | 0.070 |
Why?
| | Aging | 1 | 2018 | 1966 | 0.060 |
Why?
| | Complement System Proteins | 1 | 2009 | 316 | 0.060 |
Why?
| | Anti-Bacterial Agents | 3 | 2012 | 1915 | 0.060 |
Why?
| | CD4 Lymphocyte Count | 1 | 2006 | 277 | 0.060 |
Why?
| | RNA, Viral | 2 | 2006 | 688 | 0.060 |
Why?
| | Female | 3 | 2023 | 78376 | 0.060 |
Why?
| | Klebsiella Infections | 1 | 2005 | 26 | 0.060 |
Why?
| | Pneumonia, Bacterial | 1 | 2005 | 113 | 0.050 |
Why?
| | HIV Protease Inhibitors | 1 | 2004 | 69 | 0.050 |
Why?
| | Virus Latency | 1 | 2004 | 90 | 0.050 |
Why?
| | Principal Component Analysis | 1 | 2004 | 198 | 0.050 |
Why?
| | Viral Load | 1 | 2006 | 526 | 0.050 |
Why?
| | Brain | 1 | 2014 | 2941 | 0.040 |
Why?
| | Phycobilisomes | 1 | 2020 | 2 | 0.040 |
Why?
| | Carbon Cycle | 1 | 2020 | 14 | 0.040 |
Why?
| | Synechococcus | 1 | 2020 | 11 | 0.040 |
Why?
| | Policy | 1 | 2021 | 147 | 0.040 |
Why?
| | Organelles | 1 | 2020 | 57 | 0.040 |
Why?
| | Fluorescence | 1 | 2020 | 161 | 0.040 |
Why?
| | T-Lymphocytes | 2 | 2006 | 1982 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2004 | 1990 | 0.040 |
Why?
| | Cell Nucleus | 1 | 2021 | 619 | 0.030 |
Why?
| | Carbon Dioxide | 1 | 2020 | 242 | 0.030 |
Why?
| | Light | 1 | 2020 | 411 | 0.030 |
Why?
| | Complement C3 | 2 | 2009 | 191 | 0.030 |
Why?
| | Receptors, Metabotropic Glutamate | 1 | 2014 | 37 | 0.030 |
Why?
| | Dendritic Spines | 1 | 2014 | 69 | 0.030 |
Why?
| | Amidohydrolases | 1 | 2013 | 32 | 0.020 |
Why?
| | Receptor Cross-Talk | 1 | 2013 | 21 | 0.020 |
Why?
| | Polysaccharides, Bacterial | 1 | 2013 | 67 | 0.020 |
Why?
| | Equipment Contamination | 1 | 2013 | 71 | 0.020 |
Why?
| | Central Venous Catheters | 1 | 2013 | 53 | 0.020 |
Why?
| | Bacteriological Techniques | 1 | 2012 | 68 | 0.020 |
Why?
| | Culture Media | 1 | 2012 | 161 | 0.020 |
Why?
| | Mice | 2 | 2008 | 18365 | 0.020 |
Why?
| | Quality Improvement | 1 | 2020 | 1291 | 0.020 |
Why?
| | Colorado | 1 | 2021 | 4564 | 0.020 |
Why?
| | Attention | 1 | 2014 | 458 | 0.020 |
Why?
| | Trans-Activators | 1 | 2013 | 405 | 0.020 |
Why?
| | Opsonin Proteins | 1 | 2009 | 19 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2011 | 321 | 0.020 |
Why?
| | Complement Activation | 1 | 2013 | 411 | 0.020 |
Why?
| | Serum | 1 | 2009 | 59 | 0.020 |
Why?
| | Luminescent Measurements | 1 | 2009 | 76 | 0.020 |
Why?
| | Health | 1 | 2009 | 81 | 0.020 |
Why?
| | Cyclophosphamide | 1 | 2008 | 266 | 0.020 |
Why?
| | Diet | 1 | 2014 | 1275 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2014 | 2832 | 0.020 |
Why?
| | Models, Immunological | 1 | 2006 | 100 | 0.010 |
Why?
| | Serratia Infections | 1 | 2005 | 8 | 0.010 |
Why?
| | Monte Carlo Method | 1 | 2006 | 155 | 0.010 |
Why?
| | Serratia marcescens | 1 | 2005 | 18 | 0.010 |
Why?
| | Galactose | 1 | 2005 | 34 | 0.010 |
Why?
| | T-Lymphocytes, Cytotoxic | 1 | 2006 | 177 | 0.010 |
Why?
| | Mice, Mutant Strains | 1 | 2005 | 299 | 0.010 |
Why?
| | Sepsis | 1 | 2009 | 641 | 0.010 |
Why?
| | Pregnancy | 1 | 2014 | 7191 | 0.010 |
Why?
| | Logistic Models | 1 | 2006 | 2119 | 0.010 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2006 | 1129 | 0.010 |
Why?
| | Mutation | 1 | 2005 | 4099 | 0.010 |
Why?
| | Lung | 1 | 2005 | 4109 | 0.010 |
Why?
|
|
Bortz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|